ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,228.26
-1.04%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Hemogenyx Pharmaceuticals Plc (HEMO) Quote

Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc (HEMO)

LSE
1.565
-0.002
(-0.13%)
Closed May 05 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.565
Bid
1.53
Ask
1.60
Volume
6,130,743
1.53 Day's Range 1.53
1.125 52 Week Range 6.30
Market Cap
17.473M
Previous Close
1.567
Open
1.53
Last Trade
621
@
1.6
(O)
Last Trade Time
Financial Volume
93,800p
VWAP
1.53
Average Volume (3m)
16,384,017
Shares Outstanding
1,141,999,321
Dividend Yield
-
PE Ratio
-4.37
Earnings Per Share (EPS)
-0
Revenue
-
Net Profit
-3.98M

About Hemogenyx Pharmaceuticals Plc

Sector
Finance Services
Industry
Finance Services
Website
hemogenyx.com
Headquarters
London, Gbr
Founded
1970
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.57p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.125p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,141,999,321 shares outstanding. The market capitalization of Hemogenyx Pharmaceuticals is £17.47 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.37.

HEMO Latest News

More News

EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout

The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not se ...

April 25 2024
Alliance News

Hemogenyx Pharmaceuticals PLC Final Results

Hemogenyx Pharmaceuticals PLC 25 April 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF LAW IN THE UNITED...

April 25 2024
RNS Regulatory News

Hemogenyx Pharmaceuticals PLC Total Voting Rights

Hemogenyx Pharmaceuticals PLC 28 March 2024   28 March 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   Total Voting Rights   Hemogenyx Pharmaceuticals...

March 28 2024
RNS Regulatory News

Hemogenyx Pharmaceuticals raises money for leukaemia treatment

Hemogenyx Pharmaceuticals PLC on Thursday said it has raised GBP3.3 million through a placing. Hemogenyx is a London ...

February 29 2024
Alliance News

Hemogenyx Pharmaceuticals PLC Placing to Raise US$4.2 million

Hemogenyx Pharmaceuticals PLC 29 February 2024   29 February 2024   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT...

February 29 2024
RNS Regulatory News

Hemogenyx shares rise on potential for CBR to treat brain diseases

Hemogenyx Pharmaceuticals PLC on Friday said research has shown that its proprietary chimeric bait receptor can be de ...

February 16 2024
Alliance News

Hemogenyx Pharmaceuticals PLC CBR Brain Delivery

Hemogenyx Pharmaceuticals PLC 16 February 2024   16 February 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   CBR Brain Delivery   Chimeric Bait Receptors...

February 16 2024
RNS Regulatory News

Hemogenyx says CBR can be used intranasally to treat viral infections

Hemogenyx Pharmaceuticals PLC on Wednesday said its chimeric bait receptor can be delivered intranasally in the form ...

February 14 2024
Alliance News

Hemogenyx Pharmaceuticals PLC CBR Intranasal Delivery

Hemogenyx Pharmaceuticals PLC 14 February 2024   14 February 2024   Hemogenyx Pharmaceuticals plc  ("Hemogenyx Pharmaceuticals" or the "Company")   CBR Intranasal Delivery   Chimeric Bait...

February 14 2024
RNS Regulatory News

IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold

euticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - US Food & Drug ...

February 09 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.083-5.036407766991.6481.681.5345132271.56281587DE
4-0.133-7.832744405181.6981.71.5384056101.61600313DE
12-4.735-75.15873015876.36.31.53163840172.30845677DE
26-0.585-27.20930232562.156.31.53107373162.43079943DE
52-0.51-24.5783132532.0756.31.12588845652.18124661DE
156-1.46-48.26446280993.0256.31.075106812342.05634312DE
260-1.135-42.0370370372.715.3751.0587624073.36753071DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

Discussion

View Full Feed
Zorax Zorax 4 minutes ago
The one she is trying to be vp for?
newmedman newmedman 5 minutes ago
If you can remember, she opened up the state to the Sturgis Rally in the middle of all that and tons of people got sick, then brought it all back home to their states..

You can't possibly find a more evil person than her.
Wise Man Wise Man 6 minutes ago
No, scammer. Both ideas are written in different sentences, separated by a full stop.
Fannie Mae says that:
Available capital excludes the stated value of the senior preferred stock.
Then,
we had positive net worth under GAAP $82 billion
You have lied, making up a
FNMA
MomsSpaghetti MomsSpaghetti 6 minutes ago
💩💩💩
STEV
Zorax Zorax 8 minutes ago
💥BOOM💥
? Up over 60% for the week? Bullshit as usual. 36. high to 49. high of 13 bucks is not 60%.
April 30 to 3 can't even make it hold each close. But then again using unicorn math like pumpers do does that for you.
DJT
Boatguy Boatguy 12 minutes ago
Still hopeful but have not heard anything
WPFH
Horsts Horsts 20 minutes ago
SuperCom Path To $250M In Revenues By 2018

Jan. 22, 2014 2:27 PM ET | 1 comment | About: SPCB

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)

SuperCom (SPCB) is a relat
SPCB
jxyzobrien jxyzobrien 20 minutes ago
dalton this week
https://www.youtube.com/watch?v=y9uISt95Jy8
deepdj011 deepdj011 23 minutes ago
BTC Today $ 65000 !
COIN
tredenwater2 tredenwater2 25 minutes ago
“How many drugs are out there that reduce brain atrophy?”

Or fix chromatin remodeling? Or help alleviate insomnia/sleep disturbances from which most CNS conditions come from due to lack of REM sleep? All this and more with NO AE’s or expensive transfusions in clinics!
AVXL
Mojocash Mojocash 26 minutes ago
? Up over 60% for the week? Say what!!!!! How about YTD ? Lmao!!!! Traders making huge bank on this "scam". Classic!!!!
DJT
dinogreeves dinogreeves 27 minutes ago
Not worth your time nor energy. Do you ever stop by on the side of street and ask someone why they talk to themselves or what is the point for them doing graffiti on the walls? You just can't reason with crazy. I was running errands the other day, decided to pull over for some In and Out burgers,
TGLO
newmedman newmedman 29 minutes ago
yeah, but I've just never been a big city guy.. Even logging all my years downtown, it was out of need, not purpose. I grew up here, next to the forest preserves and the wildlife. I couldn't ever imagine myself having a space downtown and the lifestyle that comes with it.. It's for s
Dodger1 Dodger1 29 minutes ago
One scotch one whiskey one beer...John lee hooker

Youtube....John lee hooker, james cotton, koko taylor.....and figure the rest out!!

$AABB
AABB
Tunafish1 Tunafish1 32 minutes ago
Yes, I would love to see a positive earning report, let’s go Lucid! They make a superior E.V., it should be recognized.
LCID
tredenwater2 tredenwater2 33 minutes ago
“Missling playing the brilliant mind, with no clue how it really works. Then indeed you may better give up and sell of.”

Last time I checked he knows exactly how it works. In fact, Kun Jin, ex lead biostatician for the fda knows exactly how it works as well nd chose to join our compan
AVXL
wadegarret wadegarret 38 minutes ago
Value, that's a ridiculous analogy

I mean the stock price of a company is largely based on revenue and eps growth vs expectations of analysts. Expectations by analysts are respected to the extent that beating them or not(and more importantly- guidance) is what almost always dict
CoinOp CoinOp 38 minutes ago
Accumulation got EBET to hit .395 on 4/8 very significant indeed! didn't hold YET because the pending motion to dismiss has not been removed YET.

Pretty good .395 with all those dockets and some filings out there right

I can just imagine what the reaction will be when t
EBET
aredrooster aredrooster 39 minutes ago
https://investorshub.advfn.com/uimage/uploads/2014/11/14/frjnmthrowing_money_out_the_window.gif
NAK
boston127 boston127 41 minutes ago
Do the company investors want another RS?

That doesn't make sense. Even if they doubled the price, by splitting the shares in half, we would barely be above $1. With the recent cash flow numbers so good, and the metaverse projects on the table, cannot understand the crash in price.
LGHL
D8c00p3r D8c00p3r 44 minutes ago
Burba in London June 18-19...acceptance testing and commission complete, they gonna wait for Chile acceptance letter or make 2 monumental announcements this month.

Oxy, BHE....swipe right
IBATF

Your Recent History

LSE
HEMO
Hemogenyx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved